PRODUCTS & SERVICES

Bio International Pharma Ltd.

Exclusive Supplier of Natural Heme Iron in Yemen

Bio International Pharma Ltd. is the exclusive supplier of natural heme iron in Yemen, reflecting its established market position and the confidence international manufacturers place in its operational and regulatory capabilities.

PRODUCTS & SERVICES

Focused Portfolio. Integrated Distribution Capability.

PORTFOLIO OVERVIEW

Bio International Pharma Ltd. manages a strategically curated portfolio of prescription pharmaceuticals, biological products, and biosimilar therapeutics sourced from international manufacturing partners. Portfolio development is guided by therapeutic focus alignment, cold chain handling capability, regulatory feasibility, and demonstrated healthcare demand within Yemen.
The company emphasizes therapeutic areas where operational discipline, specialized infrastructure, and structured market access create measurable value for both manufacturers and healthcare providers.

THERAPEUTIC AREAS

Endocrinology & Diabetes

Endocrinology & Diabetes

Insulin (human and analogue formulations) managed under validated 2–8°C cold chain conditions across storage and transport stages.

Growth Disorders

Growth Disorders

Recombinant human growth hormone (rHGH) maintained within strict temperature-controlled environments to preserve product integrity.

Hematology & Cardiovascular

Hematology & Cardiovascular

Unfractionated and low molecular weight heparin products handled under controlled storage protocols.

Immunization & Preventive Care

Immunization & Preventive Care

Vaccines requiring strict 2–8°C storage and documented temperature monitoring across all distribution stages.

General Prescription Pharmaceuticals

General Prescription Pharmaceuticals

Branded and generic medicines stored in GDP-compliant facilities with structured inventory management.

Biosimilar Therapeutics

Biosimilar Therapeutics

Biological and biosimilar products managed under product-specific handling protocols and regulatory oversight.

DISTRIBUTION & LOGISTICS CAPABILITY

Bio International Pharma Ltd. manages the full pharmaceutical distribution cycle:

  • International freight coordination (sea and air)
  • Customs clearance management
  • GDP-compliant warehousing with segregated storage areas
  • Temperature-controlled primary and branch storage
  • Structured inventory control (FEFO-based)
  • Dedicated distribution fleet including refrigerated transport
  • Last-mile delivery across multiple governorates.

Batch-level documentation and temperature monitoring are maintained throughout the supply chain to safeguard product integrity and ensure traceability.

COLD CHAIN SPECIALIZATION

Cold chain management is a core operational capability.

Temperature-sensitive products are maintained under validated 2–8°C conditions from international freight through final delivery. Controls include:

  • Continuous data logger monitoring
  • Refrigerated warehousing with backup power systems
  • Calibrated temperature recording devices
  • Documented excursion reporting protocols
  • Validated insulated packaging for last-mile delivery

This infrastructure supports safe distribution of insulin, recombinant growth hormone, heparin, vaccines, and other biological therapies.

MARKET ACCESS & REGULATORY SUPPORT

Bio International Pharma Ltd. provides structured support for international manufacturing partners entering or expanding within Yemen:

  • Dossier preparation coordination
  • SBDMA submission management
  • Marketing authorization follow-up
  • Registration renewals
  • Regulatory documentation maintenance

This integrated model reduces complexity for manufacturers by consolidating regulatory coordination and distribution under one accountable partner.

TENDER & INSTITUTIONAL SUPPLY

The company maintains structured capability in government and institutional procurement frameworks, including:

  • Tender identification and documentation preparation
  • Bid submission coordination
  • Contract fulfillment management
  • Compliance documentation and reporting

Government tenders represent a significant portion of institutional engagement, reflecting established credibility within formal procurement systems.

MARKETING & FIELD REPRESENTATION

A trained field team provides professional engagement with healthcare institutions across public and private sectors, supporting:

  • Product awareness programs
  • Scientific engagement with healthcare professionals
  • Account management
  • Institutional relationship development

All promotional activities adhere to applicable SBDMA pharmaceutical regulations and ethical standards.

SUPPLY PLANNING & CONTINUITY

Supply continuity is supported by:

  • Demand forecasting
  • Defined safety stock levels
  • Multi-modal freight arrangements
  • Structured reorder coordination
  • Contingency planning for logistical disruptions

These measures reinforce reliability for long-term manufacturing partners and healthcare institutions.